Sentinel lymph node mapping in early stage of endometrial and cervical cancers

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 361

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

DTOGIMED03_045

تاریخ نمایه سازی: 26 بهمن 1398

Abstract:

Background and Aim : The sentinel lymph node (SLN) is defined as the first chain node in the lymphaticbasin that receives primary lymphatic flow. If the SLN is negative for metastatic disease, then other nodesare expected to be disease-free. SLN techniques have been extensively applied in the staging and treatmentof many tumors, including melanoma, breast and vulvar cancers. This study aims to evaluate our techniquein SLN mapping in early stage endometrial and cervical cancers.Methods : We scheduled a cross-sectional pilot study for patients undergoing staging surgery forendometrial and cervical cancer from November 2012 to February 2014 in Beheshti and SadoughiHospitals. Our SLN mapping technique included 1 h preoperative or intraoperative injection of 4 ml of 1%methylene blue dye in the tumor site. At the time of surgery, blue lymph nodes were removed and labeledas SLNs. Then systematic lymph node dissection was completed, and all of the nodes were sent forpathologic examination concerning metastatic involvement. All of the sentinel nodes were first stained withhematoxylin and eosin and examined. Those negative in this study were then stained withimmunohistochemistry using anti-keratin antibody. Descriptive statistics, sensitivity, negative predictivevalues (NPV), false negative (FN) and detection rates were calculated.Results : Twenty-three patients including 62% endometrial and 38% cervical cancers enrolled in the study.Median of SLN count in the endometrial and cervical cancers was 3 and 2, respectively. Among endometrialand cervical cancers, detection rate of metastatic disease was 80% and 87.5%, respectively. The FN ratefor this technique was 0 and the sensitivity and NPV are 100% for both endometrial and cervical cancers.Conclusion : Considering the lower risk of metastases in early stage of both endometrial and cervicalcancers, SLN technique allows for confident and accurate staging of cancer.

Authors

Tagossadat Allameh

associate professor, fellowship of gynecology oncology , Isfahan University of Medical sciences

Tajossadat Allameh

associate professor, fellowship of gynecology oncology , Isfahan University of Medical sciences

Vahidehsadat Hashemi

obstetrician and gynecologist, isfahan, iran

Fereshteh Mohammadizadeh

professor, pathologist , Isfahan University of Medical sciences